HER2 as a potential therapeutic target on quiescent prostate cancer cells

HER2 as a potential therapeutic target on quiescent prostate cancer cells

Quiescent prostate cancer (PCa) cells are common in tumors but are often resistant to chemotherapy. Quiescent PCa cells are also enriched for a stem-like tumor initiating population, and can lead to recurrence after dormancy. Unfortunately, quiescent PCa cells are difficult to identify and / or targ...

Full description

Bibliographic Details
Main Authors: Kenji Yumoto, Jibraan Rashid, Kristina G. Ibrahim, Steven P. Zielske, Yu Wang, Maiko Omi, Ann M. Decker, Younghun Jung, Dan Sun, Henriette A. Remmer, Yuji Mishina, Laura A. Buttitta, Russell S. Taichman, Frank C. Cackowski
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Translational Oncology
Subjects:
Dormancy
HER2
ERBB2
Quiescent
Prostate cancer
Disseminated tumor cells
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323000281

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323000281

Similar Items